Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is a common hormonal disorder in women that can lead to serious health problems.

Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Acne is strongly linked to high BMI, hair loss, menstrual issues, family history, and eating too many sweets and fatty foods, but not to excessive hair growth.

Treating PCOS is complex, involving medication like metformin and lifestyle changes, and requires attention to mental health due to high depression and anxiety rates.

People with hypothyroidism and hair loss often have more hair and scalp issues than those without thyroid problems.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Mutations in the AR gene cause hair thinning and loss.

The birth control pill containing ethinylestradiol and chlormadinone may help treat acne and other skin and hair conditions related to hormones.

A child with low platelets and anemia was later found to have lupus.

Classical PCOS types A and B are most common and linked to higher health risks.

PCOS may increase the risk of certain cancers.

Women with PCOS are much more likely to experience depression.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

Female relatives of PCOS patients have a higher chance of showing PCOS symptoms.

PCOS requires personalized treatment to improve life quality and reduce health risks.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Certain skin symptoms can help detect and manage systemic lupus.

Oral Vitamin D can improve hair density and reduce hair loss in Telogen Effluvium patients.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

Lifestyle changes improve reproductive function and hormonal balance in obese women with PCOS.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

A model using hormone levels, cycle length, and BMI can help identify PCOS in Chinese women but isn't for screening teens.